LENZ Therapeutics Statistics

Total Valuation

LENZ has a market cap or net worth of $834.53 million. The enterprise value is $652.44 million.

Market Cap	834.53M
Enterprise Value	652.44M

Important Dates

The last earnings date was Wednesday, May 7, 2025, after market close.

Earnings Date	May 7, 2025
Ex-Dividend Date	n/a

Share Statistics

LENZ has 28.15 million shares outstanding. The number of shares has increased by 917.91% in one year.

Current Share Class	28.15M
Shares Outstanding	28.15M
Shares Change (YoY)	+917.91%
Shares Change (QoQ)	+0.12%
Owned by Insiders (%)	2.76%
Owned by Institutions (%)	43.25%
Float	12.00M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	28.13
PB Ratio	4.31
P/TBV Ratio	4.40
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 23.09, with a Debt / Equity ratio of 0.01.

Current Ratio	23.09
Quick Ratio	22.64
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -24.47% and return on invested capital (ROIC) is -18.96%.

Return on Equity (ROE)	-24.47%
Return on Assets (ROA)	-17.75%
Return on Invested Capital (ROIC)	-18.96%
Return on Capital Employed (ROCE)	-30.86%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, LENZ has paid $1,000 in taxes.

Income Tax	1,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +65.01% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+65.01%
50-Day Moving Average	27.48
200-Day Moving Average	26.93
Relative Strength Index (RSI)	55.87
Average Volume (20 Days)	247,195

Short Selling Information

The latest short interest is 3.33 million, so 11.84% of the outstanding shares have been sold short.

Short Interest	3.33M
Short Previous Month	3.38M
Short % of Shares Out	11.84%
Short % of Float	27.77%
Short Ratio (days to cover)	17.72

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-59.45M
Pretax Income	-117.37M
Net Income	-47.74M
EBITDA	-59.36M
EBIT	-59.45M
Earnings Per Share (EPS)	-$1.77

Full Income Statement

Balance Sheet

The company has $193.98 million in cash and $1.18 million in debt, giving a net cash position of $192.79 million or $6.85 per share.

Cash & Cash Equivalents	193.98M
Total Debt	1.18M
Net Cash	192.79M
Net Cash Per Share	$6.85
Equity (Book Value)	192.01M
Book Value Per Share	6.97
Working Capital	189.29M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$51.50 million and capital expenditures -$578,000, giving a free cash flow of -$52.08 million.

Operating Cash Flow	-51.50M
Capital Expenditures	-578,000
Free Cash Flow	-52.08M
FCF Per Share	-$1.85

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LENZ does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	-917.91%
Shareholder Yield	-917.91%
Earnings Yield	-5.65%
FCF Yield	-6.16%

Dividend Details

Analyst Forecast

The average price target for LENZ is $41.80, which is 40.98% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$41.80
Price Target Difference	40.98%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1